Tenaya Therapeutics, Inc. 8-K

What Happened

• On May 6, 2026, Tenaya Therapeutics, Inc. (TNYA) announced and furnished to the SEC a press release reporting its financial results for the quarter ended March 31, 2026. The full text of that Earnings Press Release is attached to the Form 8-K as Exhibit 99.1 and is incorporated by reference into the filing.

Key Details

• Filing date: May 6, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: Quarter ended March 31, 2026 (Q1 2026).
• Exhibit: Earnings Press Release attached as Exhibit 99.1 to the 8-K.
• Legal note (Item 9.01): The press release is furnished, not “filed,” and therefore is not subject to Section 18 liability and is not automatically incorporated by reference into other SEC filings.

Why It Matters

• This 8-K notifies investors that Tenaya has released its quarterly earnings/financial results; the press release likely contains key metrics such as revenue, net income/loss, cash position, and business updates. Investors should read Exhibit 99.1 (the press release) for the actual numbers and details, and look for the company’s subsequent 10-Q or investor call for the complete financial statements and management discussion. The filing’s “furnished, not filed” status is a legal designation that limits certain liabilities and incorporation into other filings.